Table 1

Overview of diabetes guidelines in Asia

No.Country (publisher)Population size (millions)24Title (year published)Diabetes prevalence (%)1DR prevalence (%)STDR prevalence (%)
1China (COS)1376.0Diagnosis and Treatment Guideline of Diabetic Retinopathy (2014)2510.623265.227
2Hong Kong (PC)7.3Hong Kong Reference Framework for Diabetes Care for Adults in Primary Care Settings (2013)2810.23929 309.829
3Japan (JDS)126.6Treatment Guide for Diabetes (2014–2015)317.623.332Unavailable
4Malaysia (MOH)30.3Screening of Diabetic Retinopathy Clinical Practice Guidelines (2011)3316.636.8341534
5Palestine (MOH)4.7Diabetes Mellitus Guideline356.51136Unavailable
6Philippines (DA)100.7Philippine Practice Guidelines on the Diagnosis and Management of Diabetes Mellitus (2014)376.161.83820*38
7Saudi Arabia (MOH)31.5Guidelines for Diabetes (2013)3917.636.84017.540
8Singapore (MOH)5.6Diabetes Mellitus. MOH Clinical Practice Guidelines (2014)4112.833.9428.942
9Sri Lanka20.7Management of Diabetes Mellitus Clinical Practice Guidelines438.527.444Unavailable
10Turkey (SEMT)78.7Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up of Diabetes Mellitus and its Complications (2010)4512.530.546Unavailable
11United Arab Emirates (MOH)9.2National Diabetes Guidelines (2009)4714.61948Unavailable
  • *PDR only.

  • COS, Chinese Ophthalmological Society; DA, Diabetes Philippines; DR, diabetic retinopathy; JDS, The Japan Diabetes Society; MOH, Ministry of Health; PC, primary care; PDR, proliferative diabetic retinopathy; SEMT, The Society of Endocrinology and Metabolism of Turkey; STDR, sight-threatening diabetic retinopathy.